ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Melanoma and other Skin Tumours
Latest ESMO videos
Featured medwireNews
Time Of Day At Infusion May Alter ICI Outcomes For Advanced Melanoma
Long-Term COLUMBUS Data Confirm Encorafenib–Binimetinib PFS Benefit in Advanced Melanoma
Adjuvant PD-1 Inhibitor Chronic Immune-Related AEs Highlighted In Advanced Melanoma
Stage III High-Risk Melanoma Benefits With Dabrafenib–Trametinib, Pembrolizumab
Continuous BRAF–MEK inhibition Best For BRAF-Mutated Melanoma
E-Learning
ESMO E-Learning: Metastatic Melanoma Treatment
ESMO V-Learning: BRAF Mutations Across Cancers
ESMO V-Learning: Inhibition of MEK to Treat Cancer, focussing on Melanoma
Factsheets on Biomarkers
PD-L1 in Cancer: ESMO Biomarker Factsheet
NRAS in Melanoma: ESMO Biomarker Factsheet
BRAF in Melanoma: ESMO Biomarker Factsheet
Meeting resources
Melanoma advanced and adjuvant
Presenter: Victoria G. Atkinson, AU
Session: Session 5 - Recent advances with ICPI: Results in approved/unapproved indication – part 2
Resources:
Slides
Webcast
Discussion
Presenter: Andrew Furness
Session: Current standards and practice changing studies in sarcomas and melanomas
Resources:
Webcast
An Asian patient clinical case focusing on ‘Before’ and ‘After’ the implementation of the practice-changing studies in the local/national context
Presenter: Jyoti Bajpai
Session: Current standards and practice changing studies in sarcomas and melanomas
Resources:
Slides
Webcast
Practice changing studies in Melanomas
Presenter: Andrew Furness
Session: Current standards and practice changing studies in sarcomas and melanomas
Resources:
Slides
Webcast
Targeting mRNA translation initiation in melanoma
Presenter: Stephan Vagner
Session: Transcription and translation inhibitors in cancer treatment
Resources:
Slides
Webcast